methionine has been researched along with Carcinoma, Ductal, Pancreatic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Avizonis, D; Chang, CJ; Chio, IIC; Christian, AH; Feng, H; Friedman, RA; Grandgenett, PM; He, D; Hollingsworth, MA; Kluger, MD; Klute, KA; Monnin, C; Powers, J; Sundberg, B; Thomas, CJ; Toste, FD; Wilkinson, JE; Yang, J | 1 |
Abbruzzese, JL; Bi, Y; Hu, L; Huang, H; Ji, J; Kim, E; Li, X; Li, Z; Liu, M; Lu, W; Luo, CK; Luo, Y; Ma, J; Wang, D; Wang, G; Yang, VW; Zhu, L | 1 |
2 other study(ies) available for methionine and Carcinoma, Ductal, Pancreatic
Article | Year |
---|---|
Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis.
Topics: Carcinoma, Pancreatic Ductal; Carrier Proteins; Humans; Membrane Proteins; Methionine; Methionine Sulfoxide Reductases; Oxidation-Reduction; Pancreatic Neoplasms; Pyruvate Kinase; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
Selective killing of cancer cells harboring mutant RAS by concomitant inhibition of NADPH oxidase and glutathione biosynthesis.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreatic Ductal; Cell Death; Colonic Neoplasms; Enzyme Inhibitors; Female; Genes, p53; Genes, ras; Glutamate-Cysteine Ligase; Glutathione; HCT116 Cells; Humans; Methionine; Mice, Nude; Mice, Transgenic; Mutation; NADPH Oxidases; Onium Compounds; Ovarian Neoplasms; Oxidative Stress; Pancreatic Neoplasms; Signal Transduction; Sulfoxides; Tumor Burden; Xenograft Model Antitumor Assays | 2021 |